IACP Position Statement: HR 3204 - The Drug Quality and Security Act
What Does it Say? What Does it Mean? What Happens Now?
HR 3204 - also known as The Drug Quality and Security Act - as currently worded does two things which directly impacts compounding pharmacy practitioners. It creates a new type of FDA regulated business called an "outsourcing facility" and it retains and clarifies the existing section 503 (a) of the Food Drug and Cosmetic Act which governs pharmacy compounding.
Click here to review HR 3204.
IACP Position Statement
Click here to read IACP's entire Position Statement on HR 3204.
Click here to read IACP's Press Release Statement Distributed on the Wire Regarding its Compromise Compounding Bill
October 1 Town Hall Recording
Today's IACP Town Hall recording is now available in the Members-only site. Click on Member Resources, and then Town Hall Recordings. Please email with any questions to email@example.com.
Endorsement/Neutral/Opposition Position Letters to Congress
Click here to read NCPA's Compromise Bill Endorsement Letter to Congress.
Click here to read PCCA's Compromise Bill Neutrality Letter to Congress.
Click here to read Letco Medical's Compromise Bill Opposition Letter
Additional Association Letters of Support
American Society for Radiation Oncology
American Society of Clinical Oncology
American Society of Health-System Pharmacists
Bladder Cancer Advocacy Network
Cancer Support Community
Fight Colorectal Cancer
General Pharmaceutical Association
Healthcare Distribution Management Association
International Myeloma Foundation
Kidney Cancer Association
Lymphoma Research Foundation
National Coalition for Cancer Survivorship
National Lung Cancer Partnership
National Patient Advocate Foundation
Ovarian Cancer National Alliance
Pancreatic Cancer Action Network
Prevent Cancer Foundation
Richie's Specialty Pharmacy
Sarcoma Foundation of America
Susan G. Komen Advocacy Alliance
The Children's Cause for Cancer Advocacy
The Leukemia & Lymphoma Society